SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-000842
Filing Date
2024-01-31
Accepted
2024-01-31 16:54:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 ARCUTIS BIOTHERAPEUTICS, INC. p24-0547sc13g.htm SC 13G 75397
2 JOINT FILING AGREEMENT p24-0547exhibit99.htm EX-99.1 7449
  Complete submission text file 0000902664-24-000842.txt   84519
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Subject) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91349 | Film No.: 24583706
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)